Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ABUS

Arbutus Biopharma Corp

May 08 • 10:13AM ET

4.33

-0.02 -0.37 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: ARWR VIR ALNY NTLA ENTA

| Held by: VTI IWM XBI VXF IWO IBB VTWO SCHA KOMP VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.18	Insider Own	20.68%	Shs Outstand	192.53M	Perf Week	0.32%
Market Cap	853.54M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	156.22M	Perf Month	0.79%
Enterprise Value	766.26M	PEG	-	EPS next Q	-0.03	Inst Own	63.58%	Short Float	11.40%	Perf Quarter	12.86%
Income	-33.50M	P/S	60.62	EPS this Y	32.35%	Inst Trans	1.76%	Short Ratio	7.84	Perf Half Y	-5.99%
Sales	14.08M	P/B	10.90	EPS next Y	-	ROA	-29.60%	Short Interest	17.80M	Perf YTD	-9.90%
Book/sh	0.40	P/C	9.33	EPS next 5Y	-	ROE	-38.52%	52W High	5.10 -15.02%	Perf Year	31.33%
Cash/sh	0.46	P/FCF	-	EPS past 3/5Y	27.58% 29.45%	ROIC	-41.76%	52W Low	2.94 47.41%	Perf 3Y	66.05%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-28.80% 15.29%	Gross Margin	97.42%	Volatility	3.88% 4.43%	Perf 5Y	54.23%
Dividend TTM	-	EV/Sales	54.42	EPS Y/Y TTM	53.54%	Oper. Margin	-192.08%	ATR (14)	0.18	Perf 10Y	4.43%
Dividend Ex-Date	-	Quick Ratio	15.73	Sales Y/Y TTM	128.21%	Profit Margin	-237.88%	RSI (14)	48.65	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	15.73	EPS Q/Q	70.45%	SMA20	-0.92%	Beta	0.62	Target Price	5.25
Payout	-	Debt/Eq	0.05	Sales Q/Q	-33.23%	SMA50	-2.10%	Rel Volume	0.11	Prev Close	4.35
Employees	19	LT Debt/Eq	0.05	Earnings	Mar 23 BMO	SMA200	1.17%	Avg Volume	2.27M	Price	4.33
IPO	Jul 23, 2007	Option/Short	Yes / Yes	EPS/Sales Surpr.	71.51% 71.03%	Trades		Volume	37,064	Change	-0.37%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)